Promise & Pitfalls of Tumor Target Quantification in Antibody-Drug Conjugate & Immune Cell Engager Drug Development
- Target expression in indication selection and as potential predictive biomarkers
- Digital pathology approaches and technical challenges
- Optimizing program investment and deciding what data will be enough